SCHEMBL34469560

SCHEMBL34469560

[2H]C([2H])([2H])n1cc(C(=O)OC)cc1-c1ccc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 1/20 0.47
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MAPK14 Q16539 6/20 0.39
▸ KDM4A O75164 1/20 0.39
▸ KDM5A P29375 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SLC9A1 P19634 1/20 0.36
▸ ACLY P53396 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34469989 0.91 ALPL (0.50) ALPLNPC1RAB9AMAPTLMNA
SCHEMBL34469806 0.87 KDM4A (0.47) ALPLLMNAALDH1A1MAPK14KDM4A
SCHEMBL34469568 0.83 KDM4E (0.43) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL25314484 0.82 ALPL (0.46) ALPLNPC1RAB9AMAPTLMNA
SCHEMBL34470148 0.80 ALDH1A1 (0.41) ALPLNPC1RAB9AMAPTLMNA
SCHEMBL34469931 0.80 ALPL (0.44) ALPLNPC1RAB9AMAPTLMNA
SCHEMBL34469812 0.79 TDP1 (0.42) ALPLRAB9AMAPTLMNASMN1; SMN2
SCHEMBL34469840 0.79 MAPK14 (0.41) ALPLNPC1RAB9AMAPTLMNA
SCHEMBL34470214 0.78 KDM4A (0.49) ALPLMAPTLMNASMN1; SMN2ALDH1A1
SCHEMBL34469524 0.78 MDM4 (0.41) ALPLNPC1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 — — WO disclosed
Send feedback